Inhaled leukotriene E(4), but not leukotriene D(4), increased airway inflammatory cells in subjects with atopic asthma.
about
Cysteinyl leukotriene overproduction in aspirin-exacerbated respiratory disease is driven by platelet-adherent leukocytesFunctional recognition of a distinct receptor preferential for leukotriene E4 in mice lacking the cysteinyl leukotriene 1 and 2 receptorsLeukotriene E4-induced pulmonary inflammation is mediated by the P2Y12 receptorWhat we know about nonsteroidal anti-inflammatory drug hypersensitivityBiological effects of leukotriene E4 on eosinophilsCysteinyl leukotrienes and their receptors; emerging conceptsThe leukotriene E4 puzzle: finding the missing pieces and revealing the pathobiologic implicationsMultifaceted roles of cysteinyl leukotrienes in eliciting eosinophil granule protein secretionIdentification of GPR99 protein as a potential third cysteinyl leukotriene receptor with a preference for leukotriene E4 ligandEosinophils and Mast Cells in Aspirin-Exacerbated Respiratory Disease.Leukotriene E4 is a full functional agonist for human cysteinyl leukotriene type 1 receptor-dependent gene expression.Role of Leukotrienes and Leukotriene Modifiers in Asthma.Cysteinyl leukotrienes acting via granule membrane-expressed receptors elicit secretion from within cell-free human eosinophil granules.Platelet-driven leukotriene C4-mediated airway inflammation in mice is aspirin-sensitive and depends on T prostanoid receptors.Asthma, airway biology, and nasal disorders in AJRCCM 2001.Characterisation of P2Y(12) receptor responsiveness to cysteinyl leukotrienes.Leukotriene E4 activates human Th2 cells for exaggerated proinflammatory cytokine production in response to prostaglandin D2.Endogenous secreted phospholipase A2 group X regulates cysteinyl leukotrienes synthesis by human eosinophils.P2Y12 antagonist attenuates eosinophilic inflammation and airway hyperresponsiveness in a mouse model of asthma.Placenta growth factor augments airway hyperresponsiveness via leukotrienes and IL-13.Leukotriene E4 activates peroxisome proliferator-activated receptor gamma and induces prostaglandin D2 generation by human mast cells.Role of adenosine receptors in the treatment of asthma and chronic obstructive pulmonary disease: recent developments.Prostaglandin E2 deficiency causes a phenotype of aspirin sensitivity that depends on platelets and cysteinyl leukotrienes.An update on the role of leukotrienes in asthma.Predictors of asthma control and lung function responsiveness to step 3 therapy in children with uncontrolled asthma.Mast cells in allergic asthma and beyond.Leukotriene modifiers for asthma treatment.Cysteinyl leukotriene receptors, old and new; implications for asthma.Pathogenesis of aspirin-exacerbated respiratory disease and reactions.Group 2 innate lymphoid cells are recruited to the nasal mucosa in patients with aspirin-exacerbated respiratory disease.Systems pharmacology models can be used to understand complex pharmacokinetic-pharmacodynamic behavior: an example using 5-lipoxygenase inhibitors.Cysteinyl Leukotrienes in Eosinophil Biology: Functional Roles and Therapeutic Perspectives in Eosinophilic DisordersCutting edge: Leukotriene C4 activates mouse platelets in plasma exclusively through the type 2 cysteinyl leukotriene receptor.Systemic prednisone administration selectively alters granulocyte subsets in nasal polyps from aspirin-exacerbated respiratory disease and chronic rhinosinusitis patients.Cysteinyl leukotrienes promote human airway smooth muscle migration.Effects of montelukast and budesonide on airway responses and airway inflammation in asthma.Increased leukotrienes in exhaled breath condensate in childhood asthma.Effect of the addition of montelukast to inhaled fluticasone propionate on airway inflammation.Provocation with adenosine 5'-monophosphate, but not methacholine, induces sputum eosinophilia.The effect of pranlukast on allergen-induced bone marrow eosinophilopoiesis in subjects with asthma.
P2860
Q24633568-2DC20A2E-C674-4090-9360-D70F12BEF320Q24646354-1C4729B1-023F-4438-A72A-552F73F0920AQ24647514-E5B9C64B-89D7-4E53-BE2E-6FCE94A69AF2Q26749250-19BC6411-404A-4431-B421-60D339A58ED5Q28238927-1613AAEB-945C-4992-903F-F3420AE483E2Q28243252-64A007BF-0AB6-46CB-B72C-2534616592A2Q28253643-B234EEC1-6D00-49FA-A910-ABC0E508E1FBQ28260328-2DA747AD-9C8E-4D0E-BF0B-6F03650D3375Q28287399-2C371D16-A1B8-40D7-9EA8-B3CCF142D28EQ30275780-D5EF3B3A-6B49-45D3-88AD-DDD9AC8E792AQ30360923-533D0D9B-0CB8-4069-9841-E844E9C6925EQ33664150-6939C64C-C91D-46B9-963B-1BC020299C66Q33669090-0665605D-0C9C-47CC-ADFD-E4EAB6BD5D49Q34473270-73809038-FBA8-439D-9453-5816AA899F0FQ34550135-15299A74-2CB6-4F42-ABDA-0C372C4EFB58Q34614905-3C8678CD-3AF8-4B36-81B9-F7E749FDA1FAQ35738005-2ED29351-062D-4DC4-8F3F-4A267AB771E7Q36414954-770C55EE-4B23-493C-ADEB-8F6B9ACFFED3Q36504328-80B6C500-E19A-4FC9-90FB-571A47458453Q36515104-D906AFEE-64F7-428F-B75D-2A9591D4FC1FQ36711106-6945B9A5-72B3-40E4-965A-C097FA135A13Q36717198-0DCC68D0-67FB-46BC-A3D9-1304682C947BQ37240446-3B1BF10C-FCD1-4AD2-8725-B46C7FCC2FD9Q37633331-45FA47BB-6F07-467A-B5CE-10C4D978AA32Q37649821-E8B5015E-154C-4A42-A878-E4A0B527EA90Q37794115-CE38CD93-3434-457C-816F-D3DCD09E077BQ37808003-E14BA903-A875-4D19-8B0B-558DA5D9F534Q38038319-30829231-A72F-4DE9-ABBA-0215246932E9Q38103710-15FAFEBC-F501-4239-8052-14DF4EF4F3A3Q38916857-4F8D9B6E-7975-486E-920D-D8866A27B902Q39756267-B93063B4-8C06-4D84-BE83-630F8CFA5BD2Q41044958-B56BCA46-7922-4D85-98A1-D4BF7D76CC2DQ42153378-5A559580-EF29-4937-B1BD-1BA5AFA99016Q43475763-A360C715-24DB-446D-93A4-2CDDFBB4370EQ44120922-20F1F1E6-1890-41B6-A31D-5725F1DDFF17Q44196721-AC82069D-9C60-419F-B0F5-E55D9143C28EQ44198490-85A0BF4C-C5AE-48B4-BF23-BE5B9936212CQ44248031-0B9BE833-B13A-472F-9FA6-0D0651DCA3CFQ44726558-A9E7537F-9492-48F3-A248-789A73C4463FQ44741246-0C168E44-0CC6-45BB-A303-E34A407A725F
P2860
Inhaled leukotriene E(4), but not leukotriene D(4), increased airway inflammatory cells in subjects with atopic asthma.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Inhaled leukotriene E(4), but ...... n subjects with atopic asthma.
@en
Inhaled leukotriene E(4), but ...... n subjects with atopic asthma.
@nl
type
label
Inhaled leukotriene E(4), but ...... n subjects with atopic asthma.
@en
Inhaled leukotriene E(4), but ...... n subjects with atopic asthma.
@nl
prefLabel
Inhaled leukotriene E(4), but ...... n subjects with atopic asthma.
@en
Inhaled leukotriene E(4), but ...... n subjects with atopic asthma.
@nl
P2093
P2860
P1476
Inhaled leukotriene E(4), but ...... n subjects with atopic asthma.
@en
P2093
Gauvreau GM
O'Byrne PM
Parameswaran KN
P2860
P304
P356
10.1164/AJRCCM.164.8.2102033
P407
P433
P577
2001-10-01T00:00:00Z